Association of Glucagon-like Peptide 1 Analogs and Agonists Administered for Obesity with Weight Loss and Adverse Events: A Systematic Review and Network Meta-analysis

BACKGROUND: Comparative effectiveness of 7 glucagon-like peptide 1 (GLP-1) agents on weight loss (WL) in obesity remains unknown. METHODS: We performed a systematic review, network meta-analysis (NMA) utilizing the following data sources: MEDLINE, EMBASE, Scopus, Cochrane Central and clinical trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Vosoughi, Kia, Atieh, Jessica, Khanna, Lehar, Khoshbin, Katayoun, Prokop, Larry J., Davitkov, Perica, Murad, M. Hassan, Camilleri, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633575/
https://www.ncbi.nlm.nih.gov/pubmed/34877513
http://dx.doi.org/10.1016/j.eclinm.2021.101213

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633575/
https://www.ncbi.nlm.nih.gov/pubmed/34877513
http://dx.doi.org/10.1016/j.eclinm.2021.101213

Ejemplares similares